BioMed Partners Closes Second Fund
BioMed Partners, a Swiss venture capital firm focused on the European healthcare sector, has closed its second fund with CHF 106 million ($104 million) in capital commitments. The firm also hired veteran pharma exec Karl Deres as a venture partner. Most recently, Deres had been running his own pharma consulting firm.
13 January 2010•3 mins read
